Quarterly report pursuant to Section 13 or 15(d)

Consolidated Statements of Cash Flow

v3.21.1
Consolidated Statements of Cash Flow - USD ($)
 3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Operating activities    
Net income (loss) for the year $ (7,372,000) $ (3,641,000)
Items not affecting cash:    
Stock based compensation 231,000 234,000
Net realizable value adjustments 1,673,000 2,282,000
Amortization of mineral properties 509,000 657,000
Depreciation of capital assets 446,000 454,000
Accretion expense 123,000 145,000
Amortization of deferred loan costs 12,000 17,000
Provision for reclamation 0 3,000
Mark to market loss (gain) 3,404,000 (273,000)
Unrealized foreign exchange loss (gain) 296 (15)
Accounts receivable (2,000) 16,000
Inventory (1,719,000) (2,189,000)
Prepaid expenses 204,000 111,000
Accounts payable and accrued liabilities 119,000 74,000
Cash Provided By (Used in) Operating Activities (2,076,000) (2,125,000)
Investing activities    
Decrease (increase) in bonding and other deposits 0 (5,000)
Purchase of capital assets 0 (18,000)
Net Cash Provided by (Used in) Investing Activities 0 (23,000)
Financing activities    
Issuance of common shares and warrants for cash 15,237,000 0
Share issue costs (1,307,000) 0
Proceeds from exercise of warrants and stock options 1,439,000 0
Net Cash Provided by (Used in) Financing Activities 15,369,000 0
Effects of foreign exchange rate changes on cash 35,000 (10,000)
Increase (decrease) in cash, cash equivalents, and restricted cash 13,328,000 (2,158,000)
Beginning cash, cash equivalents, and restricted cash 12,127,000 15,215,000
Ending cash, cash equivalents, and restricted cash $ 25,455,000 $ 13,057,000